Medicine Markets

Active Markets (2)

Before Oct 1, 2026

Market Model 1.0% 0.8%

Before Jul 1, 2027

Market Model 40.0% 38.4%

7.0K contracts Refresh

Before 2027

Market Model 70.0% 66.2%

Before November

Market Model 64.0% 33.3%

15.7K contracts Refresh

Event	Market	Model	Conf	TI
Will the FDA approve cytisinicline for smoking cessation? Top outcome: Before Oct 1, 2026	1.0%	0.8%	High	67	Refresh
When will the FDA reclassify BPC-157 to Category 1? Top outcome: Before 2027	70.0%	66.2%	High	77	Refresh

Expired Markets (1)

Before Oct 1, 2026

Market Model 13.0% 4.6%

Before Jan 1, 2027

Market Model 6.0% 30.1%

12.3K contracts

Event	Market	Model	Conf	TI
Will the FDA approve camizestrant for advanced breast cancer? Top outcome: Before Oct 1, 2026	13.0%	4.6%	High	—